DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
144	レノックス・ガストー症候群	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00518713 (ClinicalTrials.gov)	August 2007	20/8/2007	Clobazam in Patients With Lennox-Gastaut Syndrome	Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Clobazam in Patients With Lennox-Gastaut Syndrome	Epilepsy;Epilepsy, Generalized;Seizures	Drug: Clobazam Low Dose;Drug: Clobazam Medium Dose;Drug: Clobazam High Dose;Drug: Placebo	Lundbeck LLC	NULL	Completed	2 Years	60 Years	All	238	Phase 3	United States;Australia;Belarus;India;Lithuania;Serbia

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

August 2007

20/8/2007

Clobazam in Patients With Lennox-Gastaut Syndrome

Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Clobazam in Patients With Lennox-Gastaut Syndrome

Epilepsy;Epilepsy, Generalized;Seizures

Drug: Clobazam Low Dose;Drug: Clobazam Medium Dose;Drug: Clobazam High Dose;Drug: Placebo

Lundbeck LLC

NULL

Completed

2 Years

60 Years

All

238

Phase 3

United States;Australia;Belarus;India;Lithuania;Serbia